New Scientific Director for CIHR’s Institute of Cancer Research
Dr. Fei-Fei Liu was named Scientific Director of CIHR’s Institute of Cancer Research (ICR) effective September 1, 2022. Dr. Liu has worked for more than three decades as a Clinician Scientist at the Princess Margaret Cancer Centre, where she is also the Chief of the Radiation Medicine Program and Head of the Department of Radiation Oncology. Dr Liu’s research focuses on investigating and developing novel molecular therapeutic strategies that can be delivered in conjunction with radiation therapy for head and neck, breast, and cervical cancers. More recently, Dr. Liu and her team have focused on unraveling the fundamental mechanisms and identifying therapeutic strategies for radiation fibrosis and lymphedema. As a physician-scientist, Dr. Liu demonstrates a commitment to excellence in research and patient care, as well as a strong determination to build research capacity through training. Welcome Dr. Liu!

Today, the CCRA recognizes six leaders in Canadian cancer research, including two inaugural Indigenous awards recipients. The CCRA Awards, initiated in 2011, recognize and celebrate on a biennial basis the outstanding contributions of individuals who have had a remarkable impact on ...
Effective January 1, 2020, Dr. Don Desserud begins his term as the Patient/Family Representative on the CCRA Advisory Board. Dr. Desserud participated in the 2019 Patient Involvement in Cancer Research Project (PIP) and is a survivor of Non-Hodgkin Lymphoma.
Dr. Desserud is a Political Science professo...